Xiaowei Liu

1.0k total citations · 1 hit paper
55 papers, 714 citations indexed

About

Xiaowei Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Xiaowei Liu has authored 55 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Public Health, Environmental and Occupational Health and 14 papers in Oncology. Recurrent topics in Xiaowei Liu's work include Cancer Immunotherapy and Biomarkers (13 papers), Glaucoma and retinal disorders (7 papers) and Corneal surgery and disorders (7 papers). Xiaowei Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Glaucoma and retinal disorders (7 papers) and Corneal surgery and disorders (7 papers). Xiaowei Liu collaborates with scholars based in China, United States and Sweden. Xiaowei Liu's co-authors include Sven‐Erik Strand, Michael Ljungberg, Eric C. Frey, Katarina Sjögreen Gleisner, Yuni K. Dewaraja, Paolo Rinaudo, Wingka Lin, Annemarie A. Donjacour, Rhodel Simbulan and Enrrico Bloise and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xiaowei Liu

50 papers receiving 706 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells

2024 53 citations Pengfei Xing, Cangang Zhang et al. Cell Death and Disease profile →

Peers

Countries citing papers authored by Xiaowei Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaowei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Liu more than expected).

Fields of papers citing papers by Xiaowei Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Liu. The network helps show where Xiaowei Liu may publish in the future.

Co-authorship network of co-authors of Xiaowei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Liu. A scholar is included among the top collaborators of Xiaowei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Liu. Xiaowei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Features of Chinese Patients with Thyroid Eye Disease: A Multicenter Retrospective Study 2025 ·Thyroid ·(unknown), (unknown), (unknown), Dezhou Wei, (unknown), Yuwei Zhang, (unknown), Libin Liu, Junping Wen, Xiaowei Liu, (unknown), Wei Lu, Jianjun Liu, (unknown), (unknown), Xin Song, (unknown), Rebecca S. Bahn, (unknown)	0
2	Malonate promotes CD8+ T cell memory formation via protein malonylation 2025 ·Cellular and Molecular Immunology ·Qianqian Duan, (unknown), Liang Sun, (unknown), Wenhui Li, Xiaowei Liu, Aijun Zhang, Yong Liu, Lianjun Zhang	1
3	Succinate preserves CD8+ T cell fitness to augment antitumor immunity 2025 ·Immunity ·Kaili Ma, Hongcheng Cheng, Lin Wang, Han Xiao, Fenghua Liu, (unknown), (unknown), (unknown), Shicheng Li, Gang Wang, (unknown), Jiajia Wang, Xiaowei Liu, Hai‐Xi Sun, (unknown), Zhimin Gu, Ping‐Chih Ho, Guideng Li, Lianjun Zhang	4
4	Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells breakdown → 2024 ·Cell Death and Disease ·(unknown), (unknown), Pengfei Xing, (unknown), Cangang Zhang, Kaili Ma, (unknown), Shicheng Li, Wenhui Li, Xiaowei Liu, Baojun Zhang, Liyuan Zhang, Lianjun Zhang	53
5	Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615) 2024 ·European Journal of Cancer ·Jennifer H. Foster, Joel M. Reid, Charles G. Minard, Sarah E. Woodfield, (unknown), (unknown), Stephan D. Voss, Marvin D. Nelson, Xiaowei Liu, Stacey L. Berg, Elizabeth Fox, Brenda J. Weigel	3
6	Innovative surgical approach for trigeminal trophic syndrome: Successful healing of facial ulcers through cross‐face nerve grafts 2024 ·Head & Neck ·(unknown), (unknown), (unknown), (unknown), (unknown), Xiaowei Liu, Xiao Long, (unknown)	1
7	SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis 2023 ·Cellular and Molecular Immunology ·(unknown), Wenhui Li, Zhenghao Wang, Cangang Zhang, Yaping He, Xiaowei Liu, Kexin Tang, Weiguo Zhang, Qiaoming Long, Yong Liu, Jinping Zhang, Baojun Zhang, Lianjun Zhang	9
8	Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors 2023 ·Frontiers in Immunology ·(unknown), Huan Chen, Xiaowei Liu, Li Zhang	10
9	BRAF D594A mutation defines a unique biological and immuno-modulatory subgroup associated with functional CD8+ T cell infiltration in colorectal cancer 2023 ·Journal of Translational Medicine ·Wenjing Li, (unknown), Wenhui Li, Gong Yang, Kaili Ma, Yujie Lu, Xiaowei Liu, Lianjun Zhang, Feng Guo	3
10	Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events 2020 ·Thoracic Cancer ·Junling Zhuang, Jianhua Du, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Wei Qiu, Xiaoyan Si, Li Zhang, Yue Li, Xiaowei Liu, Hanping Wang, Daobin Zhou	29
11	Management of immune checkpoint inhibitor‐related adverse events: A review of case reports 2020 ·Thoracic Cancer ·Xiaoyan Si, Peng Song, Jun Ni, (unknown), Chun‐Xia He, Li Zhang, Xiaowei Liu, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Xu Yang, Mengzhao Wang	14
12	Management of immune checkpoint inhibitor‐related dermatologic adverse events 2019 ·Thoracic Cancer ·Xiaoyan Si, Chun‐Xia He, Li Zhang, (unknown), Xiaowei Liu, Yue Li, Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Mengzhao Wang, (unknown)	19
13	Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy 2019 ·Arthritis Research & Therapy ·Mu Wang, Panpan Zhang, Wei Lin, Yunyun Fei, Hua Chen, Jing Li, Li Zhang, Wenjie Zheng, Yongze Li, Xiaofeng Zeng, Jiaxin Zhou, Yamin Lai, Xiaowei Liu, Huadan Xue, (unknown), (unknown), (unknown), Wen Zhang	18
14	The SORL1 polymorphism rs985421 may confer the risk for amnestic mild cognitive impairment and Alzheimer's disease in the Han Chinese population 2014 ·Neuroscience Letters ·Chunhui Jin, Lili Zhang, (unknown), Xiaowei Liu, Yue Wu, Feng Zhang, Jianzhong Zhu, Guofu Zhang, Caixia Chen, (unknown), Lingyun Zhang, Jianmin Yuan, Fuquan Zhang, Lin Tian, (unknown), Zaohuo Cheng	16
15	RDH5 RETINOPATHY (FUNDUS ALBIPUNCTATUS) WITH PRESERVED ROD FUNCTION 2014 ·Retina ·Xiaowei Liu, Liang Liu, Hui Li, Fei Xu, (unknown), Ruifang Sui	10
16	Effect of Substrate Stiffness on Early Mouse Embryo Development 2012 ·PLoS ONE ·Kevin S. Kolahi, Annemarie A. Donjacour, Xiaowei Liu, Wingka Lin, Rhodel Simbulan, Enrrico Bloise, Emin Maltepe, Paolo Rinaudo	88
17	Absorbed Dose Distribution in Glioma Tumors in Rat Brain After Therapeutic Intratumoral Injection of ²⁰¹ Tl-Chloride 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Xiaowei Liu, Kjell Erlandsson, Michael Ljungberg, Leif Salford, Sven‐Erik Strand	7
18	Absorbed Dose Distribution in Glioma Tumors in Rat Brain After Therapeutic Intratumoral Injection of <SUP>201</SUP>Tl-Chloride 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), Xiaowei Liu, Kjell Erlandsson, Michael Ljungberg, Leif Salford, Sven‐Erik Strand	2
19	Crypt Cell Dosimetry for ⁹⁹ Tc ^m -Sestamibi in a New Small Intestinal Dosimetry Model 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Lena Jönsson, Xiaowei Liu, (unknown), Michael Ljungberg, Sven‐Erik Strand	3
20	3D Absorbed Dose Calculations Based on SPECT: Evaluation for 111-In/90-Y Therapy using Monte Carlo Simulations 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·Michael Ljungberg, Eric C. Frey, Katarina Sjögreen Gleisner, Xiaowei Liu, Yuni K. Dewaraja, Sven‐Erik Strand	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact